Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Trading Statement

23 Jul 2025 07:00

RNS Number : 1038S
Wilmington PLC
23 July 2025
 

23 July 2025

Wilmington plc

 

Year-end trading update

 

Wilmington plc, (LSE: WIL, 'Wilmington', 'the Group') the provider of data, information, education and training in the global Governance, Risk and Compliance ('GRC') markets, today provides a trading update for the year ended 30 June 2025.

 

Revenue growth from the Group's ongoing* businesses is expected to be 11%, led by both recent acquisitions in the HSE sector delivering double-digit percentage growth.

 

As at the half year, seven out of nine businesses grew year on year. Following the portfolio changes last year of two disposals and two acquisitions, and the continuing disruption in the US healthcare insurance market impacting our US events business over a full year, reported revenue is expected to be £101.5m (2024: £126m), with organic** revenue also having decreased 1% due to the US.

 

Operating profit from ongoing* businesses is expected to be up 11%, adjusted*** profit before tax is expected to be £27.7m (2024: £27.6m), with adjusted PBT margin up to 27% (2024: 22%).

 

Cash conversion continued to be strong at 107% of profits, with Group net cash on 30 June 2025 at £41.9m (30 June 2024: £67.8m) after the completion of the acquisition of Phoenix Health & Safety on 25 October 2024 and spending £3.4m on share buybacks.

 

Wilmington expects to publish its year end results on 22 September 2025.

 

Mark Milner, Chief Executive Officer, commented:

 

"We have seen another year of good ongoing* revenue and profit growth with both measures increasing 11%, reflecting our focus on a slimmed down higher quality portfolio of growing businesses. Margins have also continued to improve and both of our recent acquisitions have seen double digit growth. This performance came against a tough macro backdrop, particularly in the US healthcare market which has seen continued disruption in the course of our H2.

 

"With the acquisition of Phoenix, we have continued to actively manage our portfolio of businesses and are pursuing various opportunities to invest our cash in acquisitions to improve the quality of revenue and profits."

 

*Ongoing - eliminating the effects of the impact of disposals, closures and businesses held for sale.

**Organic - Ongoing, eliminating acquisitions and exchange rate fluctuations

***Adjusted profit before tax (PBT) is calculated as PBT after adding back amortisation and impairment of intangible assets (except computer software) and profits/losses on disposals and business closures. Market consensus adjusted profit before tax is £27.0m.

 

For further information, please contact:

 

Wilmington plc

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

Meare Consulting

Adrian Duffield

 

 

020 7490 0049

 

 

 

 

07990 858548

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs around 600 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUUORVWUBUAR
Date   Source Headline
1st Dec 20149:07 amRNSVoting Rights Announcement
20th Nov 20143:47 pmRNSShareholding Announcement
13th Nov 20143:40 pmRNSHolding(s) in Company
6th Nov 20145:11 pmRNSAGM Results 2014
6th Nov 20147:00 amRNSInterim Management Statement
3rd Nov 20141:39 pmRNSVoting Rights
27th Oct 201411:33 amRNSCorrection: Share Awards
20th Oct 20146:17 pmRNSCorrection: Share Awards
20th Oct 20145:10 pmRNSDirector/PDMR Shareholding
20th Oct 20145:09 pmRNSShare Awards
17th Oct 20143:54 pmRNSHolding(s) in Company
10th Oct 20144:16 pmRNSHolding(s) in Company
1st Oct 20141:46 pmRNSTotal Voting Rights
23rd Sep 201412:15 pmRNSShare Awards
18th Sep 20147:00 amRNSFinal Results
1st Sep 20145:16 pmRNSVoting Rights Announcement
1st Aug 20147:00 amRNSVoting Rights and Capital
14th Jul 20142:58 pmRNSHolding(s) in Company
14th Jul 20142:55 pmRNSHolding(s) in Company
1st Jul 201411:32 amRNSVoting Rights and Capital
23rd Jun 20149:00 amRNSNotice of Results
19th Jun 201411:05 amRNSHolding(s) in Company
12th Jun 20147:00 amRNSCEO Appointment
5th Jun 20145:26 pmRNSHolding(s) in Company
2nd Jun 201412:44 pmRNSTotal Voting Rights
2nd Jun 20149:00 amRNSHolding(s) in Company
22nd May 20142:22 pmRNSHolding(s) in Company
13th May 20147:00 amRNSInterim Management Statement
2nd May 20142:04 pmRNSVoting Rights & Capital
9th Apr 201412:36 pmRNSHolding(s) in Company
2nd Apr 201410:55 amRNSTotal Voting Rights
31st Mar 20144:30 pmRNSHolding(s) in Company
3rd Mar 20149:40 amRNSVoting Rights and Capital
25th Feb 20147:01 amRNSRetirement of Chief Executive
25th Feb 20147:00 amRNSInterim Results
17th Feb 20142:58 pmRNSHolding(s) in Company
4th Feb 20141:50 pmRNSVoting Rights and Capital
2nd Jan 20142:12 pmRNSVoting Rights and Capital
20th Dec 201311:32 amRNSNotice of Results
2nd Dec 20135:57 pmRNSTotal Voting Rights
19th Nov 20137:00 amRNSHolding(s) in Company
11th Nov 20134:48 pmRNSHolding(s) in Company
5th Nov 20133:39 pmRNSResult of AGM
5th Nov 20137:00 amRNSInterim Management Statement
4th Nov 201312:23 pmRNSTotal Voting Rights
24th Oct 201311:52 amRNSShare Awards
4th Oct 201311:42 amRNSHolding(s) in Company
2nd Oct 20134:31 pmRNSDirector/PDMR Shareholding
1st Oct 20134:51 pmRNSHolding(s) in Company
1st Oct 201311:33 amRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.